Delisting risk
VTGN · NASDAQ · Biotechnology

VistaGen Therapeutics (VTGN)

Develops intranasal pherine candidates for psychiatric, women's-health, and cancer-supportive-care conditions.

$0.2500
Pre-market+0.00 (+0.64%)
At close$0.2484(+2.10%)

Breakdown13F · 13D/G · Form 4

Institutions61 holders · as of Mar 31, 202633.20%14.73M shares
Insiders5 holders · as of Jul 2, 20260.35%155.5K shares
Strategic holders1 holder · as of Feb 17, 20269.88%4.38M shares
Otherremainder56.57%25.11M shares

44.38M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Commodore Capital LP1,2Strategic10 percent owner
9.88%4.38M13Gfiled Feb 17, 2026
Orbimed Advisors LLCInstitution
6.90%3.06M13Fas of Mar 31, 2026
TCG Crossover Management, LLCInstitution
6.03%2.68M13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
3.55%1.57M13Fas of Mar 31, 2026
Adar1 Capital Management, LLCInstitution
1.69%751,14113Fas of Mar 31, 2026
Stempoint Capital LPInstitution
1.39%616,74913Fas of Mar 31, 2026
Acadian Asset Management LLCInstitution
1.33%589,66313Fas of Mar 31, 2026
Ikarian Capital, LLCInstitution
1.17%519,07713Fas of Mar 31, 2026
Two Sigma Investments, LPInstitution
1.06%469,61913Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
1.02%453,39113Fas of Mar 31, 2026
BlackRock, Inc.Institution
1.01%448,50713Fas of Mar 31, 2026
Millennium Management LLCInstitution
0.97%430,40413Fas of Mar 31, 2026
Luminus Management LLCInstitution
0.89%396,05313Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
0.66%291,30013Fas of Mar 31, 2026
Advisorshares Investments LLCInstitution
0.62%277,11013Fas of Mar 31, 2026
Jane Street Group, LLCInstitution
0.61%272,81113Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.49%217,70013Fas of Mar 31, 2026
Verdad Advisers, LPInstitution
0.42%184,93813Fas of Mar 31, 2026
XTX Topco LtdInstitution
0.34%152,84913Fas of Mar 31, 2026
Shay Capital LLCInstitution
0.33%144,45213Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution
0.32%142,60713Fas of Mar 31, 2026
Boothbay Fund Management, LLCInstitution
0.30%134,57113Fas of Mar 31, 2026
State Street CorpInstitution
0.27%121,11413Fas of Mar 31, 2026
Tudor Investment Corp et alInstitution
0.24%106,17213Fas of Mar 31, 2026
Diadema Partners LPInstitution
0.24%105,42813Fas of Mar 31, 2026
  1. Commodore Capital LP's transaction reports restate only vehicles that traded; the 2026 ownership statement (4.38M) is used instead.
  2. Commodore Capital LP reports a block also reported by Vanguard Capital Management LLC; it is counted once, under Vanguard Capital Management LLC.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more

Institutions13F, as of Mar 31, 2026

61 holders · 14.73M shares · 16 new positions · 31 increased · 11 reduced · 15 closed

HolderShares% outstandingChg q/qFiled
Orbimed Advisors LLC3.06M6.90%0May 15, 2026
TCG Crossover Management, LLC2.68M6.03%0May 15, 2026
Vanguard Capital Management LLC1.57M3.55%+1.57MnewMay 15, 2026
Adar1 Capital Management, LLC751.1K1.69%+127.6KMay 18, 2026
Stempoint Capital LP616.7K1.39%0May 18, 2026
Acadian Asset Management LLC589.7K1.33%+589.7KnewMay 13, 2026
Ikarian Capital, LLC519.1K1.17%0May 15, 2026
Two Sigma Investments, LP469.6K1.06%+274.0KMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Commodore Capital LP9.90%4.38M13GFeb 17, 2026
Biotechnology Value Fund L P5.40%1.59M13GFeb 14, 2025

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.